Mark Waltham

Mark Waltham

Monash University

H-index: 37

Oceania-Australia

About Mark Waltham

Mark Waltham, With an exceptional h-index of 37 and a recent h-index of 18 (since 2020), a distinguished researcher at Monash University, specializes in the field of Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Molecular associations of response to the new generation BTK inhibitor zanubrutinib in marginal zone lymphoma

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma

Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients …

ALLG Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma Patients Treated with Zanubrutinib in the MAGNOLIA Trial

Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer - insight into their role in …

Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen

Mark Waltham Information

University

Position

___

Citations(all)

10288

Citations(since 2020)

1241

Cited By

9454

hIndex(all)

37

hIndex(since 2020)

18

i10Index(all)

53

i10Index(since 2020)

29

Email

University Profile Page

Google Scholar

Mark Waltham Skills & Research Interests

Cancer

Top articles of Mark Waltham

Title

Journal

Author(s)

Publication Date

Molecular associations of response to the new generation BTK inhibitor zanubrutinib in marginal zone lymphoma

Blood Advances

Maciej Tatarczuch

Mark Waltham

Jake Shortt

Galina Polekhina

Eliza A Hawkes

...

2023/3/25

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma

Leukemia

Jonathan Wong

Emily Gruber

Belinda Maher

Mark Waltham

Zahra Sabouri-Thompson

...

2022

Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients …

Matciek Tatarczuch

Mark C Waltham

Jake Shortt

Galina Polekhina

Eliza A Hawkes

...

2022

ALLG Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma Patients Treated with Zanubrutinib in the MAGNOLIA Trial

Matciek Tatarczuch

Mark C Waltham

Jake Shortt

Eliza A Hawkes

Shir Jing Ho

...

2022

Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer - insight into their role in …

Breast Cancer Research

Razan Wafai

Elizabeth D Williams

Emma de Souza

Peter T Simpson

Amy E McCart Reed

...

2020/12

Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen

Cancers

Sugandha Bhatia

Tony Blick

Cletus Pinto

Mark Waltham

James Monkman

...

2020/5

See List of Professors in Mark Waltham University(Monash University)